TS Vascular

Over TS Vascular

TS Vascular is a clinical staged company developing a patented oral tablet of Sodium Thiosulfate (STS) for chronic treatment of cardiovascular diseases. Until now, STS could only be given intravenously, limiting its potential despite strong preclinical data. Our unique formulation protects STS in the stomach and releases it in the intestine, enabling effective oral use at home. The first clinical trial, supported by Vroege Fase Financiering, will start in November 2025 and test STS as a novel therapy for Raynaud’s phenomenon

Adres

• Hoofdkantoor

  GroningenGroningen, Nederland

Team per functiegebied

Gebaseerd op 1 openbare functieprofielen, stand van 3 september 2026.

• Finance / Accounting1